Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription 30.09.2024 1 AJR Am J Roentgenol 1 Am J Surg 9 Ann Surg Oncol 4 BMC Cancer 3 Br J Cancer 3 Breast Cancer 1 Breast Cancer (Auckl) 2 Breast Cancer (Dove Med Press) 1 Breast Cancer Res 8 Breast Cancer Res Treat 4 Cancer 1 Cancer Cell 1 Cancer Lett 1 Cancer Res 3 Clin Breast Cancer 1 Clin Cancer Res 1 Clin Exp Metastasis 1 Genes Chromosomes Cancer 1 Int J Radiat Oncol Biol Phys 3 Oncogene 3 PLoS One 2 Proc Natl Acad Sci U S A 1 Radiol Imaging Cancer 3 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. CHIKARMANE SA, Slanetz PJ
   Beyond the AJR: Contrast-Enhanced Mammography Supplemental Screening in Individuals at Elevated Risk for Breast Cancer.
   AJR Am J Roentgenol. 2024 Sep 25. doi: 10.2214/AJR.24.32084.
   PubMed        
   
   

   
   Am J Surg

2. ASMAI R, Huy T, Baker JL, Yang HH, et al
   Does surgeon-performed intraoperative wire localization allow for lower margin positivity rates compared to radiologist-performed preoperative localization in early breast cancer?
   Am J Surg. 2024 Sep 21:115986. doi: 10.1016/j.amjsurg.2024.115986.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. FU MR, Liu B, Qiu JM, Sun Y, et al
   ASO Visual Abstract: The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema.
   Ann Surg Oncol. 2024 Sep 19. doi: 10.1245/s10434-024-16231.
   PubMed        
   
   
4. SHIM V, Karlea A, Habel L
   ASO Author Reflections: Mainstream Genetic Testing Makes It Feasible for a Large Integrated System to Expand the Testing Eligibility in Breast Cancer.
   Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16311.
   PubMed        
   
   
5. VASIGH M, Mohamed A, Jacobs L, Lange J, et al
   The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
   Ann Surg Oncol. 2024 Sep 27. doi: 10.1245/s10434-024-16243.
   PubMed         Abstract available
   
   
6. KIM LS, Moore MS, Schneider E, Canner J, et al
   National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer.
   Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16107.
   PubMed         Abstract available
   
   
7. DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
   ASO Visual Abstract: Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
   Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16070.
   PubMed        
   
   
8. MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
   ASO Visual Abstract: Financial Toxicity Among Women with Breast Cancer Varies by Age and Race.
   Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16091.
   PubMed        
   
   
9. SAUCKE MC, Jacobson N, McKinney G, Neuman HB, et al
   Role of the Surgeon in De-Escalating Emotion During a Breast Cancer Surgery Consultation: A Qualitative Study of Patients' Experiences in Alliance A231701CD.
   Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16156.
   PubMed         Abstract available
   
   
10. PITSINIS V, Kanitkar R, Vinci A, Choong WL, et al
    ASO Author Reflections: ICG Fluorescent-Guided Surgery for Sentinel Lymph Node Biopsy Used as a Single Tracer Shown Sensitivity, Safety, and Efficacy in Early Breast Cancer Surgery.
    Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16266.
    PubMed        
    
    
11. FREEMAN JQ, Huo D, Howard FM
    ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era.
    Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16265.
    PubMed         Abstract available
    
    

    
    BMC Cancer

12. COOK HI, Glynou SP, Sousi S, Zargaran D, et al
    Does the use of Acellular Dermal Matrices (ADM) in women undergoing pre-pectoral implant-based breast reconstruction increase operative success versus non-use of ADM in the same setting? A systematic review.
    BMC Cancer. 2024;24:1186.
    PubMed         Abstract available
    
    
13. OGUNMODEDE EO, Ajala DE, Aluko JO, Anokwuru RA, et al
    Promoting breast health among female adolescents: a comparative analysis of the effects of two didactic tools on knowledge and practice regarding breast self-examination in Southwest Nigeria.
    BMC Cancer. 2024;24:1183.
    PubMed         Abstract available
    
    
14. REZAIE-CHAMANI S, Lamyian M, Ahmadi F, Montazeri A, et al
    I trust doctors and midwives: exploring breast cancer literacy among women referring to the health centers in Iran.
    BMC Cancer. 2024;24:1201.
    PubMed         Abstract available
    
    
15. HU S, Tey SK, Kwong A
    Adipogenesis biomarkers as the independent predictive factors for breast cancer recurrence: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1181.
    PubMed         Abstract available
    
    

    
    Br J Cancer

16. CASTRO-ESPIN C, Cairat M, Navionis AS, Dahm CC, et al
    Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival: evidence from the EPIC cohort study.
    Br J Cancer. 2024 Sep 28. doi: 10.1038/s41416-024-02858.
    PubMed         Abstract available
    
    
17. PRASAD D, Baldelli E, Blais EM, Davis J, et al
    Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohort.
    Br J Cancer. 2024 Sep 25. doi: 10.1038/s41416-024-02852.
    PubMed         Abstract available
    
    
18. PHILLIPS JB, Park SS, Lin CH, Cho J, et al
    SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer.
    Br J Cancer. 2024 Sep 23. doi: 10.1038/s41416-024-02853.
    PubMed         Abstract available
    
    

    
    Breast Cancer

19. MICHAELI JC, Michaeli T, Trapani D, Albers S, et al
    Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price.
    Breast Cancer. 2024 Sep 25. doi: 10.1007/s12282-024-01634.
    PubMed         Abstract available
    
    
20. ABE T, Kataoka A, Uehiro N, Yoshida N, et al
    Desire for pregnancy and fertility preservation in young patients with breast cancer.
    Breast Cancer. 2024 Sep 25. doi: 10.1007/s12282-024-01633.
    PubMed         Abstract available
    
    
21. ENDO Y, Kotani H, Tamura N, Tanaka K, et al
    Utility of a breast biopsy clip and a point marker system in tailored axillary surgery for patients with breast cancer after neoadjuvant chemotherapy.
    Breast Cancer. 2024 Sep 23. doi: 10.1007/s12282-024-01630.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Auckl)

22. SHRESTHA P, Hsieh MC, Ferguson T, Peters ES, et al
    Higher 10-Year Survival with Breast-Conserving Therapy over Mastectomy for Women with Early-Stage (I-II) Breast Cancer: Analysis of the CDC Patterns of Care Data Base.
    Breast Cancer (Auckl). 2024;18:11782234241273666.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

23. GAO X, Bu T, Wang W, Xu Y, et al
    Comparative Analysis and Future Prospects of Human Epidermal Growth Factor Receptor 2 (HER2) and Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted Antibody-Drug Conjugates in Breast Cancer Treatment.
    Breast Cancer (Dove Med Press). 2024;16:621-630.
    PubMed         Abstract available
    
    
24. YANG X, Fan L, Huang J, Li Y, et al
    Plasma Exosome miR-203a-3p is a Potential Liquid Biopsy Marker for Assessing Tumor Progression in Breast Cancer Patients.
    Breast Cancer (Dove Med Press). 2024;16:631-643.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

25. SINN BV, Sychra K, Untch M, Karn T, et al
    On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer.
    Breast Cancer Res. 2024;26:138.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

26. GUNSTER JLB, van Duijnhoven FH, Scholten AN, Smorenburg CH, et al
    The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy.
    Breast Cancer Res Treat. 2024 Sep 26. doi: 10.1007/s10549-024-07478.
    PubMed         Abstract available
    
    
27. KESSLER AJ, Patel R, Gallagher EJ, Sheng T, et al
    Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression.
    Breast Cancer Res Treat. 2024;207:529-532.
    PubMed         Abstract available
    
    
28. TOMITA S, Yoshitake T, Matsunaga N, de Kerckhove M, et al
    Patient-reported outcomes and quality of life after breast-conserving surgery, mastectomy, and breast reconstruction assessed using the BREAST-Q questionnaire.
    Breast Cancer Res Treat. 2024;207:641-648.
    PubMed         Abstract available
    
    
29. RAJAN KK, Nijveldt JJ, Verheijen S, Siesling S, et al
    Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands.
    Breast Cancer Res Treat. 2024;207:633-640.
    PubMed         Abstract available
    
    
30. FARIA JP, Assumpcao JG, de Oliveira Matos L, Soardi FC, et al
    Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases.
    Breast Cancer Res Treat. 2024;207:615-624.
    PubMed         Abstract available
    
    
31. LEONARDIS JM, Momoh AO, Lipps DB
    Choosing breast-conserving therapy or mastectomy and subpectoral implant breast reconstruction: implications for pectoralis major function.
    Breast Cancer Res Treat. 2024;207:569-578.
    PubMed         Abstract available
    
    
32. SOLEIMANI T, Euhus D, Sogunro O, Cope L, et al
    De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion-not further characterized.
    Breast Cancer Res Treat. 2024;207:561-568.
    PubMed         Abstract available
    
    
33. SANTANA VALENCIANO A, Rivas Fidalgo S, Corral Moreno S, Gamero Medina V, et al
    Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience.
    Breast Cancer Res Treat. 2024;207:533-540.
    PubMed         Abstract available
    
    

    
    Cancer

34. ZHENG QJ, Xu L, Fan ZQ
    Reply to "A nomogram for predicting axillary node pathologic complete response-A necessary component of the path toward true axillary de-escalation but needs a clear definition of the research question and a robust study design".
    Cancer. 2024;130:3551-3552.
    PubMed        
    
    
35. GARG N, Thorat MA
    A nomogram for predicting axillary node pathologic complete response-A necessary component of the path toward true axillary de-escalation but needs a clear definition of the research question and a robust study design.
    Cancer. 2024;130:3549-3550.
    PubMed        
    
    
36. WANG X, Shang Y, Zhang J, Liu J, et al
    Survival outcomes of neoadjuvant versus adjuvant therapy in patients with T1c, node-negative, human epidermal growth factor receptor 2-positive breast cancer: A Surveillance, Epidemiology, and End Results population-based study.
    Cancer. 2024 Sep 22. doi: 10.1002/cncr.35581.
    PubMed         Abstract available
    
    
37. IYENGAR NM, Scott JM, Lee J, Lavery JA, et al
    Effects of exercise therapy on chemotherapy delivery and response in primary breast cancer: A secondary analysis of a randomized trial.
    Cancer. 2024 Sep 22. doi: 10.1002/cncr.35575.
    PubMed         Abstract available
    
    

    
    Cancer Cell

38. BOON M, Akkari L
    Architecture sets the path: Breast cancer subtypes differently shape the early brain metastatic niche.
    Cancer Cell. 2024 Sep 12:S1535-6108(24)00320-9. doi: 10.1016/j.ccell.2024.
    PubMed         Abstract available
    
    

    
    Cancer Lett

39. CHIANG CH, Xu XH, Song J, Xanthavanij N, et al
    The incidence and risk of cardiovascular events associated with pembrolizumab in patients with breast cancer.
    Cancer Lett. 2024 Sep 25:217277. doi: 10.1016/j.canlet.2024.217277.
    PubMed        
    
    

    
    Cancer Res

40. KAUR J, Adhikari M, Sabol HM, Anloague A, et al
    Single-cell Transcriptomic Analysis Identifies Senescent Osteocytes that Trigger Bone Destruction in Breast Cancer Metastasis.
    Cancer Res. 2024 Sep 23. doi: 10.1158/0008-5472.CAN-24-0857.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

41. MATTAR A, Cavalcante FP, Antonini M, Zerwes F, et al
    Letter to the Editor of Clinical Breast Cancer, on "Omitting Axillary Lymph Node Dissection is Associated With an Increased Risk of Regional Recurrence in Early Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials"
    Clin Breast Cancer. 2024 Aug 30:S1526-8209(24)00226.
    PubMed        
    
    
42. MORSE RT, Bean NW, Hall J, Deal A, et al
    Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.
    Clin Breast Cancer. 2024 Aug 30:S1526-8209(24)00228.
    PubMed         Abstract available
    
    
43. SHEPPARD VB, Tariq F, Bastiach D, Philips M, et al
    Trust in Black and White Breast Cancer Patients: Opportunities to Enhance Trustworthiness in Cancer Care.
    Clin Breast Cancer. 2024 Aug 30:S1526-8209(24)00231.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

44. DUGO M, Huang CS, Egle D, Bermejo B, et al
    The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer.
    Clin Cancer Res. 2024 Sep 23:OF1-OF10. doi: 10.1158/1078-0432.CCR-24-0149.
    PubMed         Abstract available
    
    

    
    Clin Exp Metastasis

45. MERLONI F, Palleschi M, Gianni C, Sirico M, et al
    Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives.
    Clin Exp Metastasis. 2024 Sep 23. doi: 10.1007/s10585-024-10312.
    PubMed         Abstract available
    
    

    
    Genes Chromosomes Cancer

46. OSLER TS, Brandenburg JT, Schoeman M, Chen WC, et al
    Prevalence and Reclassification of Genetic Variants in South African Populations with Breast Cancer.
    Genes Chromosomes Cancer. 2024;63:e23275.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

47. KIM N, Park W, Kim H, Cho WK, et al
    Patient-reported outcomes between whole-breast plus regional irradiation and whole-breast irradiation only in pN1 breast cancer after breast conserving surgery and taxane-based chemotherapy: A randomized phase 3 clinical trial (KROG 17-01).
    Int J Radiat Oncol Biol Phys. 2024 Sep 24:S0360-3016(24)03392.
    PubMed         Abstract available
    
    

    
    Oncogene

48. GRASSET EM, Deshpande A, Lee JW, Cho Y, et al
    Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells.
    Oncogene. 2024;43:2927-2937.
    PubMed         Abstract available
    
    
49. ZHANG C, Lu YJ, Wang M, Chen B, et al
    Characterisation of APOBEC3B-Mediated RNA editing in breast cancer cells reveals regulatory roles of NEAT1 and MALAT1 lncRNAs.
    Oncogene. 2024 Sep 25. doi: 10.1038/s41388-024-03171.
    PubMed         Abstract available
    
    
50. XIONG J, Zhou Z, Jiang Y, Li Q, et al
    Hypoxic stabilization of RIPOR3 mRNA via METTL3-mediated m(6)A methylation drives breast cancer progression and metastasis.
    Oncogene. 2024 Sep 28. doi: 10.1038/s41388-024-03180.
    PubMed         Abstract available
    
    

    
    PLoS One

51. KANEDA Y, Yamashita E, Saito H, Gonda K, et al
    Increasing trends of pharmaceutical payments to breast cancer specialists in Japan: A retrospective study from 2016 to 2019.
    PLoS One. 2024;19:e0310880.
    PubMed         Abstract available
    
    
52. LU Q, Lun D, Dawkins-Moultin L, Li Y, et al
    Study protocol for writing to heal: A culturally based brief expressive writing intervention for Chinese immigrant breast cancer survivors.
    PLoS One. 2024;19:e0309138.
    PubMed         Abstract available
    
    
53. CHEN Q, Weng Z, Lu Y, Jia Y, et al
    Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
    PLoS One. 2024;19:e0311128.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

54. ASEMOTA S, Effah W, Holt J, Johnson D, et al
    A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity.
    Proc Natl Acad Sci U S A. 2024;121:e2406837121.
    PubMed         Abstract available
    
    
55. 
    Correction for Zhang et al., HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells.
    Proc Natl Acad Sci U S A. 2024;121:e2418194121.
    PubMed        
    
    

    
    Radiol Imaging Cancer

56. FIELDS BKK, Joe BN
    Factors Influencing Probably Benign (BI-RADS 3) Radiologist Assessment at Diagnostic Mammography.
    Radiol Imaging Cancer. 2024;6:e249021.
    PubMed        
    
    

    
    Radiother Oncol

57. KAIDAR-PERSON O, Boersma L, De Brouwer P, Weltens C, et al
    The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies.
    Radiother Oncol. 2024 Sep 26:110563. doi: 10.1016/j.radonc.2024.110563.
    PubMed         Abstract available
    
    
58. VAN SCHIE P, Huisman RG, Wiersma T, Knegjens JL, et al
    Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments.
    Radiother Oncol. 2024;200:110540.
    PubMed         Abstract available
    
    
59. BOUTRY C, Moreau NN, Jaudet C, Lechippey L, et al
    Machine learning and deep learning prediction of patient specific quality assurance in breast IMRT radiotherapy plans using Halcyon specific complexity indices.
    Radiother Oncol. 2024;200:110483.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.